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ABSTRACT
The conserved bacterial transcription terminator,
Rho, is a potent target for bactericidal agents. Psu,
a bacteriophage P4 capsid protein, is capable of
inducing anti-termination to the Rho-dependent
transcription termination. Knowledge of structural
and mechanistic basis of this anti-termination is
required to design peptide-inhibitor(s) of Rho from
Psu. Using suppressor genetics, cross-linking,
protein foot-printing and FRET analyses, we
describe a conserved disordered structure, encom-
passing 139–153 amino acids of Rho, as the primary
docking site for Psu. Also a neighbouring helical
structure, comprising 347–354 amino acids, lining
its central channel, plays a supportive role in the
Rho–Psu complex formation. Based on the crystal
structure of Psu, its conformation in the capsid of
the P4 phage, and its interacting regions on Rho, we
build an energy-minimized structural model of the
Rho:Psu complex. In this model, a V-shaped dimer
of Psu interacts with the two diagonally opposite
subunits of a hexameric Rho, enabling Psu to form
a ‘lid’ on the central channel of the latter. We show
that this configuration of Psu makes the central
channel of Rho inaccessible, and it causes a mech-
anical impediment to its translocase activity.
INTRODUCTION
Rho-dependent transcription termination is an essential
and a well conserved process in most bacteria. Rho is a
hexameric molecular motor, capable of dislodging the
elongating RNA polymerase (RNAP) using its RNA-
dependent adenosine triphosphatase (ATPase) activity
that provides energy for its translocase function along
the nascent RNA (1,2). Rho binds to the rut site (Rho
utilization; a C-rich unstructured region) of the exiting
nascent RNA, and this interaction is pre-requisite for its
termination function (3). The essentiality of this protein
for bacterial survival makes it a potent target for the bac-
tericidal agents.
Rho-dependent termination induces polar effect by
reducing the expressions of the downstream genes (1,2).
The polarity in phage P2 is suppressed by a protein coded
by psu (polarity suppressor), a late gene of the Escherichia
coli phage P4 (4,5). This is a unique 21 kDa capsid-
decoration protein, which was shown to moonlight as a
transcription anti-terminator of the Rho-dependent ter-
mination (6–9). We had reconstituted the anti-Rho
function of Psu in vitro and demonstrated specific
complex formation between Rho and Psu (10). We also
showed that Psu inhibits Rho function by affecting the
latter’s adenosine triphosphate (ATP) binding, as well as
the RNA-dependent ATPase activity (10). Mutational
analyses showed that Psu C-terminal is important for its
function, and its N-terminal is required to maintain the
structural integrity (11). Recent crystal structure of Psu
revealed that it is an a-helical, V-shaped knotted dimer
(12) that directly binds to Rho through its C-terminal
helix 7 (11).
The interacting site(s) of Psu on Rho is not known.
Knowledge of the interaction surface is essential to under-
stand the molecular basis of anti-termination. In this
report, using both in vivo and in vitro techniques, we
described a conserved looped out structure, encompassing
139–153 amino acids of Rho, as the primary docking site
for Psu, and a neighbouring helical structure, spanning the
347–354 amino acids of Rho, plays a supportive role.
Based on the conformation of Psu on the capsid structure
of the P4 phage (7), its crystal structure (12), and the
experimentally determined interacting regions of Rho
and Psu, we have built a structural model of a Rho
(hexamer): Psu (dimer) complex. In this model, a dimer
*To whom correspondence should be addressed. Tel: +91 40 24749428; Fax: +91 40 24749343; Email: rsen@cdfd.org.in
Published online 22 May 2013 Nucleic Acids Research, 2013, Vol. 41, No. 14 6839–6856
doi:10.1093/nar/gkt336
 The Author(s) 2013. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which
permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloaded from https://academic.oup.com/nar/article-abstract/41/14/6839/1074615
by guest
on 28 May 2018
of Psu forms a ‘lid’ on the central channel of the
hexameric Rho. Finally, in accordance with the model,
we demonstrate that binding of Psu to Rho renders the
central channel of the latter inaccessible and imparts
mechanical impediment to its translocase activity.
MATERIALS AND METHODS
Materials
NTPs were purchased from GE Healthcare. [g-32P]ATP
(3000Ci/mmol), and [a-32P] CTP (3000Ci/ mmol) was
obtained from Jonaki, BRIT (Hyderabad, India).
Antibiotics, IPTG, lysozyme, DTT and bovine serum
albumin (BSA) were obtained from USB. Restriction
endonucleases, polynucleotide kinase and T4 DNA
ligase were obtained from New England Biolaboratories.
WT E. coli RNA polymerase holoenzyme was purchased
from Epicenter Biotechnologies. Streptavidin-coated
magnetic beads were purchased from Promega. Taq
DNA polymerase was obtained from Roche Applied
Science. Site-directed mutagenesis kit was obtained from
Stratagene. Ni-NTA agarose beads were from Qiagen and
SIGMA. Details of the bacterial strains, plasmids and
oligos are described in Supplementary Table S1.
Screening for the suppressor of C-terminal Psu mutants
in Rho
The strain RS659 (rho::kan), carrying an IPTG-dependent
shelter plasmid (pHYD 1201) expressing WT rho, was
transformed with a second plasmid pNL150 expressing
different C-terminal mutants of Psu. All these psu
were expressed from IPTG-controlled Ptac promoter.
Resulting strains were electroporated with a mutagenized
plasmid library carrying the rho [pHYD567 (13,14)].
During this process, the shelter plasmid was removed by
withdrawing IPTG from the media. The transformants
were at first streaked (patched) on LB plate to make a
master plate. Then replica plating has been done from
the master plate on different LB plates containing 50
and 100 mM of IPTG. The colonies that did not grow on
the IPTG plates were selected. Rho mutant plasmids were
isolated from these colonies, and the suppressor mutations
were confirmed by sequencing.
Preparation of other Rho mutants
Rho mutants like R144E, R146E, E148R, R149E, K352A
and V354N were made on a low copy pCL1920 plasmid
by site-directed mutagenesis using the Stratagene kit.
Deletion derivatives of Rho were made by overlap poly-
merase chain reaction (PCR) methods (15).
Single Cys derivatives of Psu and Rho
All the single cysteine derivatives of Rho and Psu were
prepared by site-directed mutagenesis, after removing
their natural cysteines (two from Psu and one from
Rho) by introducing C13S and C117S mutations in Psu
and C202S in Rho. The single Cys derivatives of Rho were
prepared on P167L Rho, instead of WT Rho. All these
derivatives were active in Rho–Psu complex formation as
was evident from the pull-down assays (Supplementary
Figure S3A and B).
Growth assays
The strain RS659 was transformed with plasmids
(pCL1920) carrying WT and mutant rho and plated on
the LB plate in the absence of IPTG. After removing the
shelter plasmid, these strains were transformed with the
plasmids carrying WT and mutant psu (derivatives of
pNL150). Serial dilutions of the overnight cultures of
each of the strains were spotted onto LB plates supple-
mented with different concentrations of IPTG
(Figure 1A), and they were grown overnight at 37C.
For the point mutants in different Psu-binding domains
of Rho, instead of serial dilutions, growth assays were
performed by streaking on the appropriate plates
(Figure 5).
In vivo pull-down assays
BL21 (DE3) strain was co-transformed with the plasmids
pET28 (KanR), expressing Psu proteins, and pET21b
(AmpR), expressing Rho proteins. Psu proteins were
His-tagged at the N-terminus. Transformants were
inoculated in 5ml of LB and were grown at 37C for
3 h. This 5ml culture was then added to 100ml of LB
and grown until OD600 0.3, following which 0.1mM
IPTG was added to induce the protein expressions, and
the induction was continued for 3 h. The cells were then
lysed in lysis buffer (100mM NaH2PO4, 100mM NaCl,
10mM imidazole, 1mg/ml of lysozyme and 10 mg/ml of
PMSF). The lysate was passed through Ni-NTA
(Qiagen) columns, washed with wash buffer (100mM
NaH2PO4, 100mM NaCl and 20mM imidazole), and
proteins were eluted with elution buffer (100mM
NaH2PO4, 100mM NaCl and 500mM imidazole). The
volumes of lysate, wash buffer and elution buffers were
kept the same for loading of the same amount of proteins
in each lane (Figures 2 and 5).
ATPase assays
The rates of ATP hydrolysis of WT and mutant Rho
proteins in the absence and presence of WT and mutant
Psu proteins were measured. H-19B cro RNA was used as
an inducer. DNA templates for transcribing the RNA
were prepared by PCR amplification from the plasmid
pRS18 using the RS421/RK23B oligo pair. The RNA
was made using the Mega transcript kit from Ambion.
The ATP hydrolysis was assayed by monitoring the
release of Pi from ATP using polyethylenimine thin-layer
chromatography (TLC) plates and 0.75M KH2PO4, pH
3.5, as a mobile phase under the following conditions. The
assays were performed in T buffer (25mM Tris–HCl, pH
8.0, 50mM KCl, 5mM MgCl2, 1mM dithiothreitol and
0.1mg/ml BSA) at 37C. The rate of ATP hydrolysis of
100 mM of ATP together with [g-32P]ATP (3500Ci/mmol;
BRIT, India) were measured using 50 nM of Rho and
5 mM of Psu, respectively. Reaction was started by
addition of 0.2mM of RNA. Aliquots were removed,
and the reactions were stopped with 1.5M formic acid
at various time points depending on the concentrations
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of ATP. Release of Pi was analysed by exposing the TLC
sheets to a Phosphor-Imager screen and subsequently by
scanning using Typhoon 9200 (GE healthcare) (Figure 2).
In vivo Rho-dependent transcription termination assays
We have used two reporter systems for the in vivo Rho-
dependent termination assays. They are galEP3 reporter,
where a series of terminators are inserted in the form of
IS2 element at the beginning of the galactose operon
(Figure 1B), and lacZ reporter system, where a double
terminator cassette, H-19BtR1-trpt’, was fused just
upstream of the lacZYA operon (Figure 5D).
The effect of the Rho suppressors was observed to be
more prominent on the galEP3 reporter system compared
with the lacZ system; therefore, we restricted ourselves to
a less quantitative indicator plate assay (Figure 1B). These
experiments were performed in the strain RS336 contain-
ing the galEP3 reporter cassette. This strain was first
transformed with the pCL1920 plasmid carrying WT
and suppressor rho genes. Resulting strains were further
transformed with pNL150 plasmids with WT and mu-
tant psu genes. The transformants were streaked on
MacConkey-glactose indicator plate and incubated at
37C till the colour was developed (Figure 1).
For other point and deletion derivatives of
Rho (Figure 5), the strain RS1128, containing the
H-19BtR1-trpt’-LacZ reporter, was first transformed with
the pCL1920 plasmid carrying WT and mutant rho genes
and was subsequently transformed with the plasmid
pBAD18, with or without WT and mutant psu. The
b-galactosidase activities from the lacZYA reporter
fused downstream of a double terminator cassette,
H-19B tR1-trpt’, give the measure of termination efficiency
at these two Rho-dependent terminators. Different strains
were grown until OD600 0.2 and were then induced with
0.001% arabinose for 1 h. This level of induction was
optimum for the measurement of b-galactosidase
activities. Measurements were performed in a microtiter
plate using Spectramax Plus plate reader [Figure 5
(13,16)].
In vitro transcription assays
The T7A1-ltR1 template used for all the transcription
assays was PCR-amplified from the plasmid pRS604
using the primers RS58 and RS147. Transcription on
this template is initiated from the strong T7A1 promoter
and proceeds through the Rho-dependent terminator ltR1.
The reactions were initiated in transcription buffer
(25mM Tris–HCl, pH 8.0, 5mM MgCl2, 50mM KCl,
1mM DTT and 0.1mg/ml of BSA) with 10 nM DNA
template, 25 nM WT RNA polymerase, 175 mM ApU,
5 mM each of GTP and ATP and 2.5 mM CTP to make
a 23mer elongation complex (EC23). [a-
32P]CTP
(3000Ci/mmol; BRIT, India) was added to the reaction
to label the EC23. This EC was then chased with 250 mM
NTPs for 10min. When required, chasing was performed
in the presence of 50 nM WT or mutant Rho proteins. To
see the effects of WT and Psu mutants on the Rho-
dependent termination, different concentrations of WT
and mutant Psu proteins were also added as indicated in
the figures (Figures 1 and 5).
Proteolytic cleavage of Rho by Fe-BABE-conjugated Psu
The single cysteine derivatives of Psu (S80C, S161C and
S181C) were dialysed overnight against metal removal
buffer [30mM MOPS and 4mM ethylenediaminete-
traacetic acid (EDTA), pH 8.2], and subsequently, the
protein samples were dialysed against Fe-BABE conjuga-
tion buffer (50mM MOPS, 100mM NaCl, 1mM EDTA,
5% glycerol, pH 8.2). After dialysis, proteins were
incubated with 5-fold molar excess of Fe-BABE (Pierce)
at 37C, in dark for 1 h. After conjugation, excess reagent
was removed by passing the reaction mixture through a
protein-desalting column (Pierce) equilibrated with Fe-
BABE protein cutting buffer (50mM MOPS, 120mM
NaCl, 0.1mM EDTA, 10mM MgCl2 and 10% glycerol,
pH 8.0). 32P-labelled, 0.2 mM P167L Rho [in the heart
muscle protein kinase (HMK)-tag at its C-terminal] and
2.5mM Fe-BABE-labelled Psu were incubated at 37C for
30min in the Fe-BABE protein cutting buffer. The
cleavage reaction was initiated by adding 4mM each of
ascorbate and hydrogen peroxide. Reaction was stopped
by adding 6 sodium dodecyl sulphate (SDS) sample
buffer. Samples were heated to 95C for 4min before
loading onto 12% SDS–polyacrylamide gel electrophor-
esis (PAGE). To identify the positions of cleavage on
Rho, molecular weight markers of the end-labelled Rho
were generated by cleavage with Cyanogen Bromide
(CNBr) and the proteases Arg-C and Lys-C.
Limited tryptic digestion of Rho in the presence of Psu
C-terminal, HMK-tagged P167L Rho protein was
radiolabelled with [g-32P] ATP (3000Ci/mmol) using
protein kinase A. The labelling reaction was done in a
buffer containing 20mM Tris–HCl (pH 8.0), 150mM
NaCl, 10mM MgCl2 and 10 mM ATP. After labelling,
0.2mM of P167L Rho was incubated with 2.5 mM of WT
Psu in transcription buffer supplemented with 1mM ATP
for 10min at 37C. This mixture was incubated with
increasing concentrations of trypsin for 1min. The reac-
tions were stopped by SDS-loading dyes, and samples
were heated to 95C for 3min before loading onto a
12–18% gradient SDS–PAGE. Molecular weight
markers of end-labelled Rho were generated in the same
way as described earlier in the text to identify the cleavage
products.
Rho–Psu cross-linking by a bi-functional cross-linker
We have used a bi-functional cross-linker, sulpho-LC-
SPDP (sulphosuccinimidyl 6-[30 (2-pyridyldithio)-
propionamido] hexanoate (Pierce), which cross-links
cysteine to amine. We first end-labelled an HMK-tagged
non-cysteine derivative of Psu (C13S and C117S) with
[a-32P]ATP (3000Ci/mmol). The primary amines
(lysines) of Psu were then labelled with SPDP by mixing
10 mM Psu and 30 mM SPDP in phosphate buffer (100mM
NaH2PO4, 150mM NaCl and 1mM EDTA, pH 7.5) for
30min at 25C. Excess SPDP was removed by passing the
mixture through a protein-desalting column (Pierce). The
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SPDP-derivatized Psu was then added to different single-
Cys derivatives of Rho and incubated for 10min at 25C
in phosphate buffer. The final concentrations of Psu and
Rho were 0.5 and 2 mM, respectively (see also the
reaction scheme in Supplementary Figure S4A).
Reactions were stopped by non-reducing SDS-sample
dye (without b-mercaptaoethanol), and loaded onto a
non-reducing 12% PAGE (Figure 4).
The single cysteine derivatives of Rho used in the afore-
mentioned experiments were constructed on the P167L
Rho by site-directed mutagenesis. These derivatives of
Rho bind Psu efficiently (Supplementary Figure S3B).
Fluorescence spectroscopy
All the fluorescence experiments were performed in the
buffer containing 10mM Tris–HCl (pH 7.0) and
100mM KCl at 25C in a Hitachi F7000 fluorescence
spectrophotometer, under CAT mode, with a PMT
voltage of 700V and scan speed of 240 nm.
Excitation of Tb-GTP (3:1; 300 mM of terbium chloride
and 100 mM of GTP) complex at 295 nm yields two
emission peaks at 488 and 547 nm. The fluorescence inten-
sity and polarization were monitored at 547 nm under dif-
ferent conditions. Fluorescence quenching was measured
using a neutral quencher, acrylamide (Sigma). Change in
fluorescence intensity at 547 nm was plotted against
increasing concentrations of acrylamide. The quenching
constant (KSV) was obtained using Stern–Volmer
equation: (F0/F)547=1+KSV[Q], where, F0 is the initial
fluorescence intensity and Q is the concentration of acryl-
amide (Figure 7).
FRET assays
The different single Cys derivatives of Rho and Psu
proteins were dialysed against the phosphate buffer
[20mM sodium phosphate (pH 7.2), 150mM NaCl and
8mM EDTA]. These were then incubated with freshly
prepared tetramethylrhodamine-5-maleimide (TMRA)
and fluorescein-5-maleimide, respectively, (dye/protein
1:1) at 22C for 15min. It was followed by incubation at
4C in the dark for overnight. The overnight incubation
was done in a thermo-mixer with the interval mixing of
15 s at 350 rpm, with a pause of 5min in between. Then the
excess dye from the protein mixture was removed by 35%
ammonium sulphate (35%) precipitation. The sample was
centrifuged at 14 000 rpm for 1 h. The supernatant was
discarded, and pellet was dissolved in the desalting
buffer (Tris 10mM, pH 8.0, KCl 100mM and EDTA
0.1mM) and kept for dialysis against the same buffer
for 7–8 h. If free dye was still present, the proteins were
also passed through Amicon ultra filters. Glycerol was
added to a final concentration of 10%, and the proteins
were stored at 20C.
All of the FRET experiments were performed in a
buffer containing 25mM Tris–HCl (pH 8.0), 50mM
KCl and 5mM MgCl2 at 25
C in a Hitachi F-7000 spec-
trophotometer. Fluorescein-labelled Psu was excited
at 470 nm, and the emission spectra were recorded for
500–650 nm. Psu and the TMRA-labelled Rho proteins
were mixed and incubated at 25C for 15min in the
cuvettes before the recording of each spectrum.
Concentrations of Psu and Rho proteins were 50 and
100 nM, respectively.
Molecular docking of Psu onto the Rho
For the Rho–Psu docking, the crystal structures of the Psu
dimer (PDB: 3RX6) and the Rho hexamer (PDB: 3ICE)
were first modified by removing the ligands and the water
molecules. The docking of the Psu dimer on the Rho
hexamer was performed using the program ‘O’ (17) that
is based on the constraints from the previous experimental
observations, results of the biochemical experiments of
this study and maintaining a symmetric interaction at
both the binding sites. The docked model so obtained
was refined using the docking refinement module in
Nomad-Ref server (18) using the default parameters.
The binding free energy of the refined docked model was
calculated using PISA (19).
RNA:DNA hybrid unwinding assays
The DNA template for this assay was made by PCR amp-
lification on the plasmid pRS106 (T7A1-trpt’-lacZYA)
using biotinylated primer RS83. A lac operator sequence
was inserted at the position+161 by using a downstream
primer having this sequence. The template (T7A1-trpt’-
lacO) was immobilized on the streptavidin-coated
magnetic beads (Promega) via the 50-end biotinylation.
Transcription reactions were initiated with 30 nM
template, and the EC23 complex was made in a similar
way as in other in vitro transcription reactions (Figures 2
and 5), except that 100 nM Lac repressor was added. EC23
was then chased in the presence of 200 mM NTPs and ri-
fampicin (10mg/ml) for 2min to make a stalled elongation
complex (RB) at the lac repressor site. The RB was
washed thoroughly to remove NTPs. RNA:DNA hybrid
was formed by adding 10 mM of antisense oligo (antisense
to the rutB site, 20 nt upstream of the 30-end of the nascent
RNA in the RB; 50-GAGGAATAAGTGACTTAGAG)
to the nascent transcript. This was followed by addition
of 50 nMWT Rho either in the absence or presence of WT
or F169V Psu proteins. The Rho was activated by adding
1mM ATP along with 10 mM of the sink-oligo (comple-
mentary to the antisense rutB oligo, 50-CTCTAAGTCAC
TTATTCCTCAGG), to ensure a single-round unwinding
reaction. The reaction was incubated at 37C for 5min
followed by addition of 0.05U/ml of RNase H. The
RNase H digestion was allowed for 1min before the
reaction was stopped by addition of phenol. The RNA
was phenol extracted and loaded onto a 10% denaturing
sequencing gel to fractionate the products.
RESULTS
Isolation of suppressors in Rho
In an earlier report, we have characterized several point
mutations in Psu that are defective for Rho binding and
established that its C-terminal region (170–190 amino
acids) directly interacts with Rho (11, see Supplementary
Figure S1A for the mutations). Hence, to get an indication
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of the Psu-interacting region(s) of Rho, we looked for the
allele-specific suppressors in Rho for the C-terminal Psu
mutants, P157L/S, R166C/P and F169V. An MG1655
strain (RS659) with a chromosomal deletion of rho
(rho::kan), carrying the plasmid pNL150 and expressing
any one of the aforementioned Psu C-terminal mutants
from an IPTG-controlled Ptac promoter, was transformed
with a low-copy pCL1920 plasmid having a mutagenized
library of rho expressed constitutively from its own
promoter. Transformants were at first obtained on LB
plates, and then each of them was replica platted on LB
plates with different concentrations of IPTG (see
‘Materials and Methods’ section for details). The expres-
sion of psu is minimal on the LB plates, whereas it is higher
on the LB+IPTG plates. High-level expression of WT Psu
proteins inhibitWTRho function and inflict lethality to the
cells (10), whereas the aforementioned C-terminal Psu
mutants can not cause this defect (11). On the replica
plates (i.e. in the presence of IPTG), we looked for rho
mutants from the mutagenized library that caused lethality
in the presence of psumutants. We obtained two such Rho
mutants, N151D and P167L that were lethal with the Psu
mutants, F169V and P157L, respectively.
We checked the growth phenotypes of different psu
mutants in the presence of these two rho mutants
(Figure 1A). Growth defects were estimated by spotting
different dilutions of overnight cultures having different
combinations of Rho and Psu mutants. Lack of cell
growth at lower dilutions indicates the Psu-induced lethal-
ity. Consistent with our previous observations (10,11),
WT Psu/WT Rho combination was lethal (leftmost
column of Figure 1A). N151D Rho specifically suppressed
the growth defects caused by F169V, P157S and P157L
Psu mutants, whereas the same defect caused by P157S,
P157L, R166P and F169V mutants of Psu was suppressed
by P167L Rho. They specifically suppressed the defects of
C-terminal mutants of Psu and not the growth defects
of N-terminal ones (E56K, L21P and S72L columns;
Figure 1A).
Rho suppressors overcome the anti-termination defects
of the Psu mutants
Next we tested whether these two Rho mutants can
overcome the anti-termination defects of the C-terminal
Psu mutants. For the in vivo anti-termination assays, we
have used MC4100 strain having a single-copy galEP3
reporter (see ‘Materials and Methods’ section) in the
chromosome. This reporter cassette consists of a series
of Rho-dependent terminators present in the IS2
element inserted at the beginning of the galactose
operon. In the presence of functional Psu, Rho is in-
hibited, and RNAP overcomes these terminators to
express downstream genes of the galactose operon.
Expression of these genes make the strain capable of
using galactose from the media that renders the formation
of pink/red colonies on the MacConkey-galactose plates.
We observed that, WT and E56K Psu proteins induced
red and white colonies, respectively, with all the Rho de-
rivatives (Figure 1B). Strains with the C-terminal mutants
of Psu appeared as white, when WT Rho was present. The
strains expressing P157S and F169V Psu proteins became
red/pink in the presence of P167L Rho. Also the strains
with P157S, P157L and F169V Psu appeared as red/pink
when N151D Rho was present. Defect because of the
R166P Psu was partially suppressed by these two Rho
derivatives. These results correlate with the suppression
of growth defects shown in Figure 1A.
The effect of the Rho suppressors were then tested
in vitro transcription assays. We have used a linear
DNA template, where transcription is initiated from the
strong T7A1 promoter, and in the presence of WT Rho, it
terminates over a zone of a Rho-dependent terminator,
ltR1. Under our experimental conditions, this terminator
functioned efficiently in the presence of WT Rho (%RT
<10%, see Figure 1D, height of the bars under Psu
conditions). The amount of run-off transcript (RO) indi-
cates the Psu-induced anti-termination at this terminator.
All the Psu mutants tested were defective in anti-
terminating the WT Rho (Figure 1C, left and Figure
1D). Interestingly, all the C-terminal Psu mutants were
able to anti-terminate P167L Rho with moderate to high
efficiency (Figure 1C, middle and histograms in Figure
1D). But, N151D Rho was efficiently anti-terminated
only in the presence of R166C Psu (Figure 1C, right). It
is likely that because of less stringent conditions in vitro,
the suppressor effects were less specific compared with
that observed in the in vivo termination assays (Figure 1B).
Rho suppressors rectify the Rho-binding defects of the
Psu mutants and their defect of inhibiting ATPase
activity of Rho
Earlier, we have reported a method to demonstrate the
in vivo Rho–Psu complex formation, by overexpressing
the two proteins from two separate plasmids (pET
vectors) having different antibiotic markers, where Psu is
histidine-tagged at its N-terminal and Rho is untagged.
The cell lysate is passed over the Ni-NTA beads, and dif-
ferent fractions are monitored on SDS–PAGE [(10) see
also ‘Materials and Methods’ section]. We co-
overexpressed the WT and the two Rho suppressors
together with different Psu mutants (Figure 2A and B).
Amounts of WT, N151D and P167L Rho obtained in the
elute (E) fractions, indicating the extent of complex for-
mation with the Ni-NTA-bound WT and different deriva-
tives of Psu, were estimated (Supplementary Figure S1B).
We observed that P167L Rho was efficiently pulled down
by WT and all the C-terminal mutants of Psu. N151D
Rho demonstrated more specific binding to WT, R166C
and F169V Psu mutants. None of the Rho derivatives
interacted with the N-terminal Psu mutant, E56K.
Compared with WT Rho, the P167L Rho seemed to
have tighter binding to WT Psu. In vivo association of
both the Rho derivates with R166C Psu was observed to
be the most efficient.
These results indicated the following. (i) The gain of
function in the Psu mutants, arose from their ability to
interact with these two Rho suppressors. (ii) The Rho
suppressors specifically bind to the C-terminal Psu
mutants. (iii) P167L Rho has an enhanced affinity for
the WT and all the C-terminal Psu mutants.
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Figure 1. Suppressors in Rho. (A) MG1655Drho strains (RS659) expressing WT, or P167L, or N151D Rho from plasmids were transformed with a
second plasmid having WT and different Psu derivatives. Different dilutions of the overnight culture of the strains were spotted on LB plates
supplemented with 100mM IPTG to check the growth defects. Dilutions are stated by the side of the figures, which is indicative of the platting
efficiencies of the different mutants. (B) MC4100 galEP3Drho strains expressing WT or P167L or N151D rho from a plasmid were transformed with
a second plasmid having WT and different Psu derivatives. Single colonies were streaked onto MacConkey-galactose plates. galEP3 reporter
produced red/pink colonies when Rho function was inhibited. (C) Autoradiogram showing the in vitro Rho-dependent transcription termination
assays of the WT and the two Rho suppressors in the presence and absence of WT and different Psu mutants. The run-off (RO) product gives the
measure of Psu-mediated anti-termination. The Rho-mediated termination zone is indicated. Concentrations of RNAP, Rho and Psu were 25 nM,
50 nM and 2mM, respectively. (D) To quantitate the anti-termination activities of different Psu derivatives, the amount of RO product was plotted as
bar diagrams. RO(%) was calculated as: [RO]/{[RO]+[terminated product]}. Error calculations were obtained from at least three measurements.
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Figure 2. Psu binding and ATPase activities of the Rho suppressors. (A and B) In vivo complex formation between different derivatives of Rho and
Psu proteins. Both His-tagged Psu and non–His-tagged Rho proteins were overexpressed from two different plasmids, and the cell-lysates were
passed through the Ni-NTA beads. Flow through (FT) and wash (W) fractions contain the unbound Rho, whereas amount of protein in elute
(E) fraction gave the measure of Psu-bound Rho. Both the proteins bands are indicated. (C–F) Amounts of ATP hydrolysis by WT and the two Rho
suppressors, both in the absence and presence of different Psu derivatives, are plotted against time. Production of g32-P from [g32-P] ATP was
monitored on the TLC plates. Amounts were calculated from the phosphorimager scans. Error bars were obtained from three measurements. The
lcro RNA used to induce ATPase function was prepared by using in vitro transcription kit. Locations of the suppressor mutations on the structure of
Rho dimer, (G) ribbon diagram and (H) space-fill model.
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Figure 3. Foot-printing analyses of the Rho–Psu complex. (A) Seven a-helices and the dimerization interface on the crystal structure of Psu
monomer are shown (left; PDB code: 3RX6). The locations of Psu mutants defective for inhibiting Rho are indicated. C-terminal tail region
(helix 7; 170–190) is in red. C-terminal point mutations at 169, 166 and 157 positions are indicated in green spheres. N-terminal mutations at 21,
56 and 72 are shown in yellow spheres. Single Cys derivatives at positions 181, 161 and 80 of Psu are indicated in red spheres (middle). An example
of the conjugation of Fe-BABE moiety to one of the Cys residues is shown in right. (B) Autoradiogram of the P32-labelled HMK-tagged P167L Rho.
Fe-BABE tagged different single Cys-derivatives of Psu were added to Rho, and the Fenton reactions were continued for indicated time. The
indicated cleavage positions were identified by comparing with the molecular weight markers generated by CNBr, ArgC and LysC. Amino acid
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Binding of Psu to Rho slows down the rate of RNA-
dependent ATP hydrolysis of the latter [(10) also compare
the slope of the plots in Figure 2C and D]. Consistent with
their lack of interaction with WT Rho, the Psu mutants,
R166C and F169V, did not show significant inhibition of
ATPase activity of the WT Rho (Figure 2E and F). But
they regained their inhibitory activity with these two Rho
suppressors (Figure 2E and F). However, the inhibitory
activity was not as strong as that observed for the WT Psu
on the WT Rho. These results were also consistent with
the other properties of P167L and N151D Rho mutants.
Based on aforementioned in vivo and in vitro assays, we
concluded that N151D and P167L mutants of Rho indeed
function as suppressors of different C-terminal mutants of
Psu, and this suppression was achieved by direct inter-
action with the Psu derivatives that led to the inhibition
of the Rho functions. However, these suppressors are not
strictly allele specific in nature. We localized these two
suppressor mutations on the Rho structure (Figure 2G
and H). They are located near the exit path of RNA
emerging out of the secondary RNA-binding channel
and are also surface exposed. It is possible that these
or nearby region(s) of Rho could be the interaction
site(s) for Psu.
Cleavage of Rho by Fe-BABE-conjugated Psu
Next we used different protein foot-printing, cross-linking
and FRET techniques to probe the interaction site(s) of
Psu on the Rho protein. We observed that, unlike WT
Rho, one of the suppressor, P167L Rho, has higher
affinity for WT Psu, and it forms a stable complex
in vitro (Supplementary Figure S2). Psu in this complex
efficiently inhibits different functions of Rho (Figures 1
and 2). And, hence, instead of WT Rho, we used P167L
Rho:WT Psu complex for all these aforementioned in vitro
assays.
We used the tethered·OH-generating reagent, Fe-
BABE ([iron (bromoacetamidobenzyl)-ethylenediaminete-
traacetate], which can be attached to Cys residues, and on
activation of·OH cleaves nucleic acids and proteins
present in its vicinity (20). We conjugated Fe-BABE to
the single cysteines of the Psu derivatives, S181C, S161C
and S80C (Figure 3A). S181C and S161C are located
within or near the Rho-interaction region of Psu,
whereas S80C is located away from this region
(Figure 3A). These single Cys substitutions did not
affect their binding to P167L Rho (Supplementary
Figure S3A).
The Fe-BABE-conjugated Psu derivatives were com-
plexed with P167L Rho in the presence of 1mM ATP.
On activation of OH-radical generation, we observed
that only Fe-BABE conjugated to the 181 position of
Psu produced two cleavage products near/at 153 and
205 amino acids positions of Rho (Figure 3B). This
cleavage product arose due to the vicinity of this
C-terminal helix 7 [marked in red, Figure 3A (12)] of
Psu to Rho, and it is consistent with the functional im-
portance of this helix in the anti-termination process (11).
The cleavage site on Rho, the amino acid 153, is located
close to the position of N151D suppressor. Therefore, this
site may define the primary interaction site for Psu.
Fe-BABE conjugated to 161 and 80 positions of Psu did
not yield any product. It is possible that because of limited
degrees of freedom of the bulky Fe-BABE moiety, there
was no cleavage from the position 161. The amino acid
80C is located far away from the interacting helix 7 (in red,
Figure 3A); hence, lack of cleavage from this position is
not unexpected.
The amino acid 205 is 27 A˚ away from the 153
position of Rho (Figure 3C). Cleavage at 205 could
define a second interaction site(s) for Psu. However,
OH-radical can travel 10 A˚ before getting quenched by
water molecules. Therefore, from the centre of Fe-BABE
moiety, this radical can cleave within a sphere with a
radius of 22 A˚ (Figure 3A, right). Therefore, it is also
possible to obtain a cleavage at position 205 that is located
away from the primary interaction site.
Protein foot-printing of the Rho–Psu complex
Next we used protease-mediated protein foot-printing of
Rho–Psu complex to identify the region(s) on Rho pro-
tected by Psu. We used limited trypsin digestion to
generate the footprint (Figure 3D). We observed that the
two prominent trypsin cleavage sites of Rho, located at
144–149 and 347–353 amino acids, were significantly pro-
tected in the presence of Psu. The footprint at 144–149
amino acids is consistent with the Fe-BABE cleavage at
the position 153 (Figure 3B), and it is situated near the
suppressor at 151 position (Figures 1 and 2). The protec-
tion at 347–353 amino acids was strong and also lies close
to the 144–149 amino acids (Figure 4D). It is likely that
region around 347–353 amino acids of Rho could be the
second interaction site for Psu, and both the interaction
sites may come even closer on interaction with Psu. The
lack of trypsin cleavage at 347–353 amino acids of Rho
could also arise from the Psu-induced conformational
changes.
Site-specific cross-linking between Rho and Psu
To further test the proximity of the previously described
three regions of Rho to the helix-7 of Psu, we constructed
three single Cys derivatives in these regions of Rho as
S153C (region 139–153), L204C (region around 205) and
S346C (region 347–353) (Figure 4A). These Rho deriva-
tives formed stable complex with Psu (Supplementary
Figure S3B). We induced cross-linking between each of
Figure 3. Continued
positions are indicated. (C) The positions 153 and 205 are indicated on the structure of Rho dimer (PDB: 2HT1). (D) Autoradiogram of P167L Rho
in the presence of different concentrations of trypsin under different conditions. The trypsin cleavage sites were identified from the size markers
obtained from the proteolytic cleavages of the same Rho molecule using different proteases as indicated. Profile plots of the cleavage intensities are
shown adjacent to the autoradiogram. Trypsin cleavage of Rho in the absence of Psu was conducted both in the presence and absence of BSA (the
+BSA lanes).
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these Cys residues of Rho, and the surface exposed lysines
of Psu via a bi-functional cross-linker, LC-SPDP
(sulphosuccinimidyl 6-[30(2-pyridyldithio)-propionamido]
hexanoate; Supplementary Figure S4A). The cross-
linking will occur if these cysteine residues of Rho come
within 15 A˚ of the surface of Psu (Supplementary Figure
S4A). We observed the formation of three kinds of cross-
linked species migrating around 45, 75 and 110 kDa,
those correspond to the sizes of a Psu dimer [2(Psu)], a
complex of Psu monomer and Rho monomer [Psu:Rho]
and a complex between Psu dimer and Rho dimer
[2(Psu):2(Rho)], respectively (Figure 4B). All these
species involved SH linkages because they were sensitive
to DTT (+DTT lanes). The 153C Rho formed a
[2(Psu):2(Rho)] complex with Psu, whereas 346C Rho
formed a [Psu:Rho] complex. No specific cross-linked
species was observed from 204C of Rho. Western blots
with Rho antibody confirmed the presence of Rho
in these two cross-linked species (Supplementary
Figure S4B).
Two SPDP adducts from the two subunits of Psu can
form di-sulphide bridges (Psu-S-S-Psu), if two lysines from
each of the subunits come within 30 A˚ (Supplementary
Figure S4C, left). If a proper geometry is achieved, as
was in the case of S153C Rho, this Psu dimer could
form a 2Psu:2Rho complex with Rho (Supplementary
Figure S4C, right). On the other hand, because of
spatial constraints, a Psu:Rho complex was formed in
the presence of S346C Rho.
These results also suggest that the region around 205
amino acid of Rho does not take part in direct interaction
with Psu. Cross-linking from the regions 139–153 amino
acids and 347–354 amino acids is indicative of the
proximity of these regions of Rho with Psu in a
Rho:Psu complex that further confirmed the observations
described in Figure 3.
FRET measurements between the Cys–Cys pairs
of Rho and Psu
To provide supporting evidence for these cross-linking
data, we measured the efficiency of FRET between the
fluorescent-labelled Cys pairs of Rho and Psu. The Cys
residues of Rho were selected from the aforementioned
cross-linking assays (Figure 4B), and those from
Psu were chosen from the Fe-BABE cleavage assays
(Figure 3B). We used the fluorophores, fluorescein (FL)
and rhodamine, as the donor–acceptor pair for these
assays. The distance for 50% energy transfer efficiency
(the Forster radius, R0) for this pair is 49–54 A˚ (21). The
single Cys derivatives of Psu, S80C, S161C and S181C,
were labelled with FL, and the two single Cys Rho deriva-
tives, S153C and S346C, with TMRA. An efficient FRET
between these Cys pairs occurs only when they come
within a distance range of 50 A˚ in the Rho–Psu
complex. In this case, if distance constraint is satisfied,
one can expect an emission around 570 nm (the emission
wavelength range of Rhodamine) on excitation at 470 nm
(excitation wavelength of FL).
Figure 4C showed that an enhancement of emission in-
tensity at 570 nm occurred when the Rho:Psu complex was
formed with all the Cys pairs, except in the cases where
S80C Psu was present (compare the panels in Figure 4C).
These results indicated an efficient FRET between 161 and
181 positions of Psu (helix 7 and loop between helices 6
and 7; see Figure 3A) with the amino acids 153C and 346C
of Rho, and they further reinforced the proposition that
regions surrounding 147–153 and 347–355 amino acids of
Rho come close to the C-terminal helices of Psu. The
FRET assays were also consistent with cross-linking and
Fe-BABE cleavage assays (Figures 3B and 4B).
Therefore, results obtained from Fe-BABE cleavage,
trypsin-foot-printing, SPDP–cross-linking and FRET un-
equivocally suggest that there are two Psu-binding regions
(PBRs; PBR1 and PBR2) in Rho, and they form a lining
around the central channel of the hexameric helicase
(Figure 4D).
Identification of Rho mutants defective for Psu function
Next we attempted to establish the functional significance
of the PBR1 and PBR2 regions of Rho in the complex
formation with Psu. We made several point mutations
and deletions in these two regions, and used in vivo and
in vitro binding and transcription assays similar to those
described in Figures 1 and 2.
From the Rho structure, we identified a looped out dis-
ordered region in PBR1 (Figure 5A). We hypothesized
that this loop region may act as a Psu-docking site, and
the highly reactive charged amino acids in this loop could
provide favourable columbic interactions. And, hence, we
constructed the following point mutants: R144E, R146E,
E148R and R149E. We also constructed two micro-
deletions, (144–148) and (149–153), in the PBR1
(Figure 5A). These changes did not induce significant sec-
ondary structure changes in the Rho proteins
(Supplementary Figure S5A).
We at first checked whether Psu can induce growth
defects to the strains having these Rho mutants. We per-
formed similar growth assays as described in Figure 1A,
and we observed that except R149E, all the mutants
showed healthy growth in the presence of Psu
(Figure 5B). This suggested that Psu was unable to
inhibit the functions of R144E, R146E and E148R
mutants of Rho. To know whether this defect of Psu
arose from its inability to bind to Rho, we monitored
the in vivo Rho–Psu complex formation by similar pull-
down assays as described in Figure 2A. All the Rho
mutants, except R149E, were unable to form complexes
with Psu (Figure 5C), as the amounts of Rho mutants
eluted reduced to the level of their non-specific adsorption
on the Ni-NTA beads (Supplementary Figure S5).
However, in the same assay, the two micro-deletions in
Rho showed partial binding defects. In these cases,
amounts of Rho were moderately higher than their non-
specific adsorption levels (Supplementary Figure S5B).
Next, we conducted in vivo and in vitro transcription
termination assays. The amounts of b-galactosidase
activities from a lacZ reporter fused downstream of a
double terminator cassette, nutR/tR1-trpt’, gave the
measure of the anti-termination efficiency through these
terminators. In these assays, Psu-induced anti-termination
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Figure 4. Chemical cross-linking and FRET analyses. (A) The locations of the single Cys residues that were labelled in the cross-linking and FRET
assays, on the structure of Rho dimer (PDB: 2HT1). (B) Autoradiogram of the radiolabelled Psu. The single Cys derivatives, made on the P167L
Rho, as indicated were mixed with SPDP-labelled Psu. Different cross-linked products are indicated, and their assignments were based on the
molecular weight. (C) Fluorescence emission spectra of Psu proteins with fluorescein-labelled at different single Cys residues, in the absence and
presence of different TMRA-labelled Rho proteins, are shown in different panels. Excitation is at 470 nm, and emission was monitored for
500–620 nm. The enhancement of emission at 570 nm is due to the FRET between fluorescein- and TMRA-labelled Cys residues of both the
proteins. Emission intensity of TMRA–Rho in the absence of Psu is shown in each panel as control. (D) The two PBRs are decorated by
coloured spheres on the hexameric structure of Rho (PDB code: 2HT1, 23).
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Figure 5. Functional importance of the PBRs. (A) A dimer of Rho showing the PBR1 region. The sequence of this region and the amino acids that
are mutated are indicated. (B) MG1655Drho strains expressing either WT or mutant rho from the plasmids were transformed with the second plasmid
having WT psu. Strains were streaked on LB plates in the presence and absence of IPTG as indicated. (C) In vivo complex formation between
different derivatives of Rho and Psu proteins. Experiments were done in the same way as in Figure 2. Flow through (FT) and wash (W) fractions
contain the unbound Rho, whereas the amounts of protein in elute (E) fraction gave the measure of Psu-bound Rho. Both the proteins bands are
indicated. Fraction of Rho associated was calculated as {[E]/[FT]+[W]+[E]}. (D) In vivo anti-termination assays of different Rho mutants. The
values of b-galactosidase activity from the lacZYA reporter fused downstream of a double terminator (tR1-trpt’) cassette is plotted. Measurements
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increases the values of b-galactosidase activities. We
observed that, unlike the WT Rho, the point mutants
did not show significant anti-termination in the presence
of Psu (Figure 5D). The (149–153) Rho showed weak
anti-termination, whereas the effect of (144–148) Rho
was moderate (Figure 5D). We also conducted in vitro
transcription assays on a linear DNA template, where a
Rho-dependent terminator, ltR1, was cloned downstream
of a strong T7A1 promoter. The run-off product (RO)
obtained in the reaction was the measure of the anti-
termination efficiency. Consistent with the in vivo assays,
the Rho point mutants were defective for Psu-mediated
anti-termination (Figure 5E).
We next tested the functional importance of PBR2 of
Rho in the Rho–Psu complex formation. We constructed
two point mutants in this region, K352A and V354N,
which are the most surface-exposed amino acids of this
region. The in vivo binding assays with these mutants
were carried out in a similar way as in Figure 5C. The
Psu-binding defect of V354N Rho was significant,
whereas it was moderate for the K352A (Figure 5F).
Even though these two mutations showed partial defects
in the in vivo complex formation with Psu, this was not
reflected in Psu-mediated in vivo anti-termination assays.
Psu was also able to induce anti-termination with these
two Rho mutants at the nutR/tR1-trpt’ terminator
cassette (Supplementary Figure S6A). As the in vivo
pull-down assays are not quantitative, we did not high-
light this defect, and we attempted to compare between the
binding and activity assays. Mutations in other two
nearby positions, 385 and 397, also did not affect the
Psu activity (Supplementary Figure S6B).
These results indicated the following. (i) PBR1, consisting
of an unstructured looped out region, is functionally im-
portant for the interactions with Psu. (ii) Less severe effect
of (144–148) indicates that this part of the loop may not
be interacting directly. However, presence of oppositely
charged amino acids in the point mutants, R144E, R146E
and E148R, might have imparted strong repelling effect on
Psu. (iii) The relatively stronger effect of the (149–153),
together with cross-linking and Fe-BABE cleavage data
strongly indicate that this part of the loop region could be
the docking site of Psu. (iv) In the Rho–Psu complex, Psu
may not make functional interaction with PBR2, but this
region stays close to the interaction surface.
A structural model of the Rho–Psu complex
We generated a structural model of Rho–Psu complex
based on the following information. (i) The distance
between the two C-terminal tail located diametrically
opposite direction from the ‘V’-shaped structure of Psu
dimer [(12) Supplementary Figure S7A)]. (ii) The
electron microgram of a Psu dimer covering the central
hole of the hexameric capsid protein, Sid [(7)
Supplementary Figure S7B)]. (iii) Interacting regions
defined by the genetic and biochemical data described in
Figures 1–5. (iv) The Rho-interacting regions of Psu
[Figure 3A; (11,12)]. (v) Inhibition of ATP binding as
well as ATPase activity of Rho by Psu (10). The ATP-
binding sites of the Rho hexamer (PDB code: 3ICE) are
located at the inter-subunit grooves, with an average
distance of 70 A˚ between the two diagonally opposite
sites. Interestingly, the distance between the beginnings
of the two C-terminal helices (a7, the Rho-interacting
region) of Psu is 60 A˚, whereas it is 80 A˚ between the
middle of a7 helices [(12) Supplementary Figure S7A)].
We docked the Psu dimer on the Rho hexamer, and we
refined the model (see the ‘Materials and Methods’ section)
using the aforementioned information. During this
modelling process, we maintained a symmetric nature of
the interaction, and we assumed that the Psu-homodimer
interacts with the Rho-homohexamer (Figure 6A
and B). The binding free energy of the docked model is
7Kcal/mol, which suggests an energetically favourable
interaction. Other configurations, using the same inter-
actions sites, were not energetically favourable.
This docking was performed without introducing major
structural alterations in Psu and Rho. In this docked
structure, a Psu dimer bridges the two diagonally
opposite inter-subunit groove of the Rho hexamer (PDB
code: 3ICE), located near the ATP and secondary RNA-
binding sites (Figure 6A and B). This configuration seems
to block the RNA exit path of Rho. There are three pairs
of potential interaction sites on the Rho hexamer, capable
of binding three Psu dimers. However, because of steric
hindrance only one dimer of Psu can bind to a Rho
hexamer at a time. The selection of the docking sites is
likely to be random. Experimentally observed 2Psu:2Rho
cross-linked species in Figure 4A and Supplementary
Figure S4C resembles the modelled configuration of a
dimer of Psu on a hexamer of Rho.
Figure 6B demonstrates a close-up view of the Rho–Psu
interaction surface. The shape and the chemical
complementarities of the docked model are evident at
several points. Psu makes most of the interactions with
Rho through its a6–a7 loop and a7 helix. The region,
Thr 168-Ala 172 (a6–a7 loop) of Psu occupies a cleft on
the surface of Rho, encompassing the residues 348–354
(PBR2). a7 of Psu is placed close to a shallow groove on
the surface of Rho, surrounded by the residues 149–154
(PBR1), indicating that this region of Rho might be
involved in direct interactions with Psu.
This configuration of Rho–Psu complex predicts that (i)
Psu dimer will block the central hole of the Rho hexamer
and (ii) its presence at the RNA exit channel will cause
mechanical obstacle to the translocase activity of Rho (see
the cartoon in Figure 6C). We validated these two predic-
tions in the following sections.
Figure 5. Continued
were made both in the absence and presence of WT psu cloned in a plasmid. Error bars were obtained from the average of five to six measurements.
(E) Autoradiogram showing the in vitro termination assays of the Rho mutants in the presence of indicated concentrations of WT Psu. DNA
template and other experimental conditions were same as in Figure 1C. (F) In vivo complex formation assays performed with the PBR2 mutants of
Rho, in a similar way as in C, having the same notations.
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Figure 6. Structural modelling of Rho:Psu complex. (A) Above: cartoon representation of the docked model showing the orientation of Psu (gold
and sky), when bound to the Rho hexamer (subunits are in magenta, yellow, salmon, green, grey and cyan in anti-clockwise manner). Below: surface
representation of the same in two orientations. ATP, BeF3 and Mg+2 molecules are shown as spheres. Psu dimer occupies the regions near the two
diagonally opposite ATP-binding sites of Rho and blocks its central channel. A 90 rotated view shows that the Psu dimer covers the central channel.
(B) A close-up view showing the residues of Psu (yellow sticks) interacting with Rho (the surface and the green sticks), having the complementarities
both in shape and chemistry. The residues of a7 of Psu are seen to be in close proximity to the region encompassing residues 151–155 (part of PBR1),
and a6–a7 loop region is close to the residues, 350–354 (part of PBR2), of Rho. These regions are indicated by dotted ovals. (C) A cartoon showing
the action of Psu as a polarity suppressor. The EC carrying a hexameric Rho on its nascent RNA is indicated. Psu dimer binds with the closed ring
state of Rho, interacts near the ATP-binding site and inhibits the translocation of the latter on the nascent RNA.
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Figure 7. Accessibility of the central channel of Rho and blocking its translocase activity. (A) Rho hexamer showing the putative location of Tb-
GTP-binding sites in the central channel. The ATP-binding amino acids are shown in red spheres, and assumed to interact also with the Tb-GTP
(13). (B) Configuration of Psu (whitish) in Rho:Psu complex blocking the access of the central channel of Rho (grey). (C) Fluorescence emission
spectra of Tb-GTP under different conditions as indicated. Fluorescence polarization (P) values of different species at 547 nm are also indicated.
(D) Stern–Volmer plots to determine the quenching constant (KSV) and the nature of quenching by a neutral quencher, acrylamide. F and Fo are
fluorescence intensities of Tb-GTP in the presence of different concentrations of acrylamide and the initial intensity, respectively. Average KSV values
are indicated. Errors were calculated from two to three measurements. (E) Cartoon showing the design of the experiment using a stalled EC
downstream of the trpt’ terminator. Site of RNA:DNA hybrid formation is indicated. (F) Autoradiogram showing the extent of cleavage of the
RNA:DNA hybrid under different conditions as indicated. RB indicates the size of the RNA emerging out of the stalled EC.
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Psu makes the central channel of Rho less accessible
A lid-like Psu dimer over the central channel of Rho
(Figure 6) is predicted to make the channel less accessible
to the solvent, and it could render the catalytic pocket less
accessible to ATP molecules (Figure 7A and B). We
probed the accessibility of this catalytic pocket by
measuring the change in fluorescence intensity and
quenching of a fluorescent analogue of GTP, Tb-GTP
(a 3:1 complex of terbium chloride and GTP). Rho can
use GTP instead of ATP, and presumably the Tb-GTP
complex binds to the same site as ATP in the central
channel (13). We observed a huge increase of fluorescence
intensity of the Rho-bound Tb-GTP in the presence of Psu
together with the increase in fluorescence polarization
(Figure 7C), which indicates a Psu-induced burial of the
catalytic pocket from the solvent. We next used fluores-
cence quenching technique to measure the accessibility of
this Rho bound Tb-GTP to the solvent. Increasing con-
centration of acrylamide, a neutral quencher, was used to
monitor the quenching of the fluorescence intensity (at
547 nm) of the Rho-bound Tb-GTP. The quenching
constant (KSV, Stern–Volmer constant), a quantitative
measure of the accessibility, was obtained from the plots
of the fluorescence intensities against the acrylamide con-
centration (Figure 7D). The KSV value reduced signifi-
cantly when Psu was bound to Rho. This further
supports the proposition that the central channel, as well
as the catalytic pocket of Rho, is less accessible, when it is
complexed with the Psu dimer.
Psu renders mechanical impediment to the translocase
activity of Rho
The configuration of Psu over the central channel of Rho
(Figure 6) is likely to offer a physical obstacle to the
helicase/translocase activity of Rho. This activity of the
Rho protein, both in the presence and absence of Psu, was
measured from the former’s potential to unwind an arti-
ficial RNA:DNA hybrid made on the nascent RNA of the
EC, stalled at a lac operator site located downstream of
the trp t’ terminator [Figure 7E (22)]. This RNA:DNA
hybrid was formed at the rutB site of this terminator
that is located just upstream of the road-blocked EC
(RB), and it is separated by >60 nt from the major Rho-
loading site, rutA. A DNA-oligo, antisense to the rutB
(anti-rutB) sequence, was used to form this artificial
RNA:DNA hybrid. We have measured the RNA:DNA
hybrid unwinding event by monitoring the sensitivity
of the RNA in the hybrid to RNase H. Presence of
a RNA:DNA hybrid makes this region sensitive to
RNase H digestion (Figure 7F, lanes 2, 6 and 14). And
this digestion was negligible, when the ATP-dependent
unwinding of this hybrid occurred by the helicase/
translocase activity of Rho (Figure 7F, lane 4). We
observed that, this region of RNA was sensitive to
RNase H under two conditions; when Rho was not
added (lane 2), and in the presence of higher concentra-
tions of Psu (lanes 10–12). This result suggests that Rho
is unable to unwind the RNA:DNA hybrids at higher
concentration of Psu. This effect of Psu was due to the
specific Rho–Psu complex formation because a Psu
mutant, F169V, did not block the unwinding activity of
Rho (lanes 15–20). Hence, we concluded that the forma-
tion of a ‘Psu-lid’ over the central channel of Rho renders
mechanical impediment to its translocation motion along
the RNA.
DISCUSSION
Bacteriophage P4 capsid protein, Psu, anti-terminates the
well-conserved transcription termination function of Rho
(8–10). In this study, we described the interaction surface,
the configuration of the Rho–Psu complex and the struc-
tural and mechanistic basis of the Psu-induced anti-
termination process. We provided the following
evidence. (i) We isolated and characterized two suppres-
sors on Rho that specifically rectified the functional
defects of the Psu mutants residing in its C-terminal
Rho-binding region (Figures 1 and 2). (ii) Using
protein–foot-printing, cross-linking and mutational
analyses, we defined two regions, residues encompassing
149–153 (PBR1) and 347–354 (PBR2) of Rho, as the Psu-
docking sites (Figures 3–5). One of the suppressors,
N151D, is located in these binding sites. (iii) A molecular
docking based on the symmetries and the structures of
Rho and Psu, configuration of Psu on the P4 capsid struc-
ture, and the aforementioned experimental results,
revealed that a V-shaped Psu dimer forms a ‘lid’ over
the central channel of Rho (Figure 6). This conformation
of the Rho–Psu complex provides the structural and
mechanistic basis of Psu-induced inhibition of ATP
binding and hydrolysis (10), and imposition of mechanical
impediments to the translocase activity of Rho along the
nascent RNA (Figure 7 and cartoon in Figure 6C).
A normal mode analysis of the Psu structure revealed
that the V-shaped Psu dimer acts as an arm, where its
knotted region resembles an elbow, allowing restricted
degrees of freedom to the dimeric-interface, but a higher
flexibility to its C-terminal tails [Supplementary Figure
S7A (12)]. Interestingly, the same dimeric scaffold is
used to recognize two unrelated hexameric proteins, Sid
of the P4 capsid and the transcription terminator, Rho.
The predicted dynamics of the C-terminal tail could play
important role in using similar mode of binding to these
different proteins. Even though the rigid-body docking of
Psu on Rho is consistent with the experimental data, we
cannot rule out the Psu-induced conformational changes
of Rho. It should also be noted that the distance between
these two helices of the Psu dimer is compatible with the
dimension of the central channel of the ‘closed’ state
hexamer of Rho [PDB: 2HT1 and 3ICE (23,24)]; hence,
it is possible that Psu targets the translocating Rho.
Both Psu and the antibiotic, bicyclomycin (BCM),
affect the ATP binding and the hydrolysis functions of
Rho (25,26). Even though the outcome of their action is
same, and their interaction sites are in close proximity
(Supplementary Figure S7C), the mechanistic basis of
their inhibition processes is different. BCM, being a
small molecule, enters deep into the central channel of
Rho and acts as a competitive inhibitor of the latter’s
ATPase activity (27), whereas Psu, on binding to the
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outer rims of this channel (Figure 6A), exerts the same
effect most likely by distorting the conformations of the
central channel.
The hexameric RNA chaperon, Hfq, has been shown
to bind and inhibit Rho by affecting the latter’s ATPase,
as well as translocase activity (28) and, hence, functions in
a similar manner as Psu. According to the symmetry of the
Hfq-hexamer, it may bind at the rim of the RNA exiting
side of the central channel of Rho, forming a ‘washer-like’
configuration. In this regard, it is likely that both Psu
and Hfq may compete with each other for the same
region of the Rho molecule in vivo.
Will Psu inhibit Rho proteins from pathogenic bacteria?
The homology models of different Rho proteins from a
diverse set of bacterial pathogens revealed that the looped
out primary docking site of Psu is well conserved, so do
their hexameric structures (Supplementary Figure S8).
These make it likely that Psu will be capable of inhibiting
Rho proteins from pathogens. As this conserved looped
out region of Rho directly interacts with the terminal helix
7 of Psu, we speculate that peptide inhibitor(s) can be
designed from the C-terminal regions of this P4 capsid
protein.
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